glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm

Современная ревматология

I A Baranova¹  Natalia Vladimirovna Toroptsova² 

[1] N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow;V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow;

关键词: glucocorticoid osteoporosis;    osteoporotic fracture;    bisphosphonates;    frax algorithm;   

DOI  :  10.14412/1996-7012-2013-2436

来源: DOAJ

【 摘 要 】

Glucocorticoids (GC) are extensively used to treat patients with systemic rheumatic diseases, which can improve their quality of life and substantially increase its span. At the same time their use is associated with the development of serious adverse reactions that cannot be always avoided. One of such complications is osteoporosis (OP) that gives rise to an increased risk for fractures. The paper gives recent clinical guidelines for the treatment and prevention of GC OP and the specific features of management in patients in relation to their age.

【 授权许可】

Unknown